{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"28"}],"title":"Total positive"},{"measurements":[{"groupId":"OG000","value":"0"}],"title":"False position"},{"measurements":[{"groupId":"OG000","value":"1"}],"title":"False negative"},{"measurements":[{"groupId":"OG000","value":"5"}],"title":"Total negative"}],"title":"Sensitivity and Specificity for Ga-68-DOTATOC as Compared to Pathology"},{"categories":[{"measurements":[{"groupId":"OG000","value":"23"}],"title":"Total positive"},{"measurements":[{"groupId":"OG000","value":"0"}],"title":"False position"},{"measurements":[{"groupId":"OG000","value":"6"}],"title":"False negative"},{"measurements":[{"groupId":"OG000","value":"5"}],"title":"Total negative"}],"title":"Sensitivity and Specificity for OctreoScan as Compared to Pathology"}],"denoms":[{"counts":[{"groupId":"OG000","value":"34"}],"units":"Participants"}],"description":"Tumor lesions detected on 68Ga-DOTATOC PET/CT compared with tumor lesions detected on Octreoscan SPECT imaging plus high-resolution, contrast-enhanced CT.","groups":[{"description":"Patients receive gallium Ga 68-edotreotide IV and undergo PET/CT scan. Within 120 days, patients undergo standard indium In 111 pentetreotide contrast-enhanced CT or MRI scan. Patients may undergo a second gallium Ga 68-edotreotide PET/CT scan within 3-6 months if the lesions of the first scan cannot be confirmed.\n\ngallium Ga 68-edotreotide: Given IV\n\npositron emission tomography/computed tomography: Undergo gallium Ga 68-edotreotide PET/CT scan\n\nindium In 111 pentetreotide: Undergo indium In 111 pentetreotide contrast-enhanced CT or MRI scan\n\ncomputed tomography: Undergo indium In 111 pentetreotide contrast-enhanced CT scan\n\ncontrast-enhanced magnetic resonance imaging: Undergo indium In 111 pentetreotide contrast-enhanced CT or MRI scan","id":"OG000","title":"Diagnostic (Gallium Ga 68-edotreotide PET/CT)"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Patients with neuroendocrine tumor or other somatostatin receptor positive tumor","reportingStatus":"POSTED","timeFrame":"Up to 6 months between the timing of the Octreoscan SPECT/CT plus high-resolution, contrast-enhanced CT and the time of the 68Ga-DOTATOC PET/CT (either imaging type may occur first)","title":"Comparison of Conventional Imaging and Gallium Ga 68-edotreotide PET Using Concordance in Tumor Detection With Pathology","type":"PRIMARY","unitOfMeasure":"Participants"}